Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
34
CMWAY Quote, Financials, Valuation and Earnings
Last price:
$93.39
Seasonality move
:
1.02%
Day range:
$93.97 - $95.50
52-week range:
$71.30 - $108.91
Dividend yield:
3.33%
P/E ratio:
24.68x
P/S ratio:
8.93x
P/B ratio:
3.36x
Volume:
34.5K
Avg. volume:
27.3K
1-year change:
19.24%
Market cap:
$157.4B
Revenue:
$17.9B
EPS (TTM):
$3.81
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $15.9B | $17.6B | $16.9B | $18.3B | $17.9B | |
| Revenue Growth (YoY) | -3.81% | 10.82% | -3.94% | 8.12% | -1.95% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $555.7M | $573.3M | $523.5M | $447.4M | $463.5M | |
| Other Inc / (Exp) | $93.3M | $17.2M | $304.5M | $180.3M | -$77.4M | |
| Operating Expenses | $7.3B | $8.2B | $8.2B | $8B | $8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $7B | $9.2B | $9.9B | $9.6B | $9B | |
| Earnings of Discontinued Ops. | $1.5B | $998.8M | $796.2M | -$65.9M | -$57M | |
| Income Tax Expense | $2B | $2.6B | $2.9B | $2.8B | $2.8B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$2M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.4B | $7.6B | $7.8B | $6.7B | $6.2B | |
| Basic EPS (Cont. Ops) | $3.64 | $4.29 | $4.50 | $3.98 | $3.68 | |
| Diluted EPS (Cont. Ops) | $3.50 | $4.03 | $4.33 | $3.89 | $3.66 | |
| Weighted Average Basic Share | $1.8B | $1.8B | $1.7B | $1.7B | $1.7B | |
| Weighted Average Diluted Share | $1.9B | $1.9B | $1.8B | $1.8B | $1.8B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $14.7B | $13.6B | $13.4B | $24B | $34.1B | |
| Revenue (Reported) | $15.9B | $17.6B | $16.9B | $18.3B | $17.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $14.7B | $13.6B | $13.4B | $24B | $34.1B | |
| Period Ending | 2015-06-30 | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2019-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $138M | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.4B | $17.6B | $17.6B | $17.9B | $18.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $623.2M | $501.2M | $590.5M | $452.2M | $483.8M | |
| Other Inc / (Exp) | -$43.5M | $248M | $408.1M | -$50.1M | -- | |
| Operating Expenses | $7.8B | $8.2B | $8.1B | $7.9B | $8.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.7B | $10.2B | $9.9B | $9.2B | $9.3B | |
| Earnings of Discontinued Ops. | $1.1B | $997.8M | -$68.8M | -$68.8M | -$11.1M | |
| Income Tax Expense | $2B | $2.9B | $3B | $2.7B | $2.8B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5.8B | $8.4B | $6.9B | $6.4B | $6.4B | |
| Basic EPS (Cont. Ops) | $3.29 | $4.76 | $4.06 | $3.81 | $3.83 | |
| Diluted EPS (Cont. Ops) | $3.12 | $4.52 | $3.92 | $3.78 | $3.81 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | $16.4B | $17.6B | $17.6B | $17.9B | $18.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-28 | 2022-03-28 | 2023-03-28 | 2024-03-28 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $19.6B | $66.5B | $82.8B | $71.5B | $32.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $228.8M | $349.4M | $337.1M | $360.8M | $420.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $55B | $94.4B | $138.1B | $122.7B | $102.7B | |
| Property Plant And Equipment | $3.8B | $4B | $3.4B | $3.3B | $2.5B | |
| Long-Term Investments | $110.1B | $109.5B | $94.9B | $90.3B | $98.5B | |
| Goodwill | $3.6B | $4B | $3.6B | $3.5B | $3.5B | |
| Other Intangibles | $1.1B | $1.2B | $1.1B | $1.4B | $1.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $697.8B | $820.4B | $836B | $829B | $838.2B | |
| Accounts Payable | $2.4B | $2.4B | $3.7B | $6.4B | $7.7B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $13.6B | $17.3B | $21.8B | $21.6B | $24.8B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $648.3B | $761.3B | $785.9B | $781.6B | $789.4B | |
| Common Stock | $26.3B | $29B | $25.2B | $22.6B | $22.6B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $49.4B | $59.1B | $50.1B | $47.4B | $48.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3.4M | $3.8M | $3.4M | $3.3M | -- | |
| Total Equity | $49.4B | $59.1B | $50.1B | $47.4B | $48.9B | |
| Total Liabilities and Equity | $697.8B | $820.4B | $836B | $829B | $838.2B | |
| Cash and Short Terms | $19.6B | $66.5B | $82.8B | $71.5B | $32.2B | |
| Total Debt | $118.1B | $105.8B | $104.3B | $106.9B | $124.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $54.1B | $101.1B | $111.4B | $67.7B | $51.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $102.1B | $115.5B | $131.6B | $88.6B | $77.1B | |
| Property Plant And Equipment | $4.2B | $3.6B | $3.4B | $3.3B | $2.3B | |
| Long-Term Investments | $138.4B | $106.3B | $95.3B | $156.3B | $144.6B | |
| Goodwill | $4.1B | $3.8B | $3.6B | $3.6B | $3.3B | |
| Other Intangibles | $1.3B | $1.3B | $1.2B | $1.5B | $1.6B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $813.2B | $833.5B | $838.4B | $869.3B | $813.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $23.9B | $15.7B | $13.7B | $14.2B | $17.4B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $755.6B | $779.4B | $789.1B | $819.7B | $766.9B | |
| Common Stock | $29.6B | $26.9B | $24B | $23.1B | $21B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3.8M | $3.6M | $3.4M | $3.4M | -- | |
| Total Equity | $57.7B | $54.1B | $49.4B | $49.6B | $46.8B | |
| Total Liabilities and Equity | $813.2B | $833.5B | $838.4B | $869.3B | $813.7B | |
| Cash and Short Terms | $54.1B | $101.1B | $111.4B | $67.7B | $51.5B | |
| Total Debt | $115.4B | $105.6B | $100.5B | $118.1B | $126.8B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $25B | $30.8B | $16.9B | -$5.6B | -$16.8B | |
| Capital Expenditures | $1B | $572.5M | $708.4M | $1.1B | $866.7M | |
| Cash Acquisitions | $3.4B | $1.1B | $2.5B | $353.9M | $58.3M | |
| Cash From Investing | $2.5B | $650.2M | $1.9B | -$587.4M | -$730.3M | |
| Dividends Paid (Ex Special Dividend) | -$5.1B | -$3.1B | -$4.7B | -$4.8B | -$5B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $30.2B | $55.9B | $52B | $40B | $37.8B | |
| Long-Term Debt Repaid | -$45.3B | -$38.9B | -$38B | -$35.6B | -$54.1B | |
| Repurchase of Common Stock | -$43.6M | -$53M | -$4.7B | -$1.8B | -$237.3M | |
| Other Financing Activities | -$77.2M | $114.2M | -- | -- | -- | |
| Cash From Financing | -$20.6B | $13.7B | $4.1B | -$2.5B | -$21.8B | |
| Beginning Cash (CF) | $11.4B | $20.4B | $63.4B | $80.3B | $70.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $6.9B | $45.2B | $22.9B | -$8.8B | -$39.3B | |
| Ending Cash (CF) | $18.4B | $65.2B | $86.5B | $72.1B | $31B | |
| Levered Free Cash Flow | $24B | $30.3B | $16.1B | -$6.7B | -$17.7B | |
| Period Ending | 2011-09-30 | 2012-09-30 | 2013-09-30 | 2014-09-30 | 2015-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $272M | $213M | $178M | |
| Depreciation & Amoritzation | -- | -- | $22M | $20M | $23M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | $399M | $605M | $281M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $352M | $460M | $505M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -$46M | $104M | $29M | |
| Cash From Investing | -- | -- | -$218M | -$353M | -$341M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$54M | -$67M | -$68M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$13M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$6M | -$1M | -$1M | |
| Cash From Financing | -- | -- | -$73M | -$68M | -$69M | |
| Beginning Cash (CF) | -- | -- | $121M | $204M | $145M | |
| Foreign Exchange Rate Adjustment | -- | -- | $3M | -$5M | -$4M | |
| Additions / Reductions | -- | -- | $61M | $48M | $95M | |
| Ending Cash (CF) | -- | -- | $185M | $247M | $236M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $26.6B | $32.1B | -- | -- | -$8.8B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | $1.3B | $1.8B | $372.6M | -- | $160.9M | |
| Cash From Investing | $513.5M | $1.4B | -- | -- | -$316.2M | |
| Dividends Paid (Ex Special Dividend) | -$3.4B | -$4.6B | -$2.3B | -$2.6B | -$5.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $36.8B | $61.4B | -- | -- | $46.2B | |
| Long-Term Debt Repaid | -$41.2B | -$36.2B | -- | -- | -$53.6B | |
| Repurchase of Common Stock | -- | -$4.4B | -- | -- | -$148.8M | |
| Other Financing Activities | -$125M | -$2.6B | -- | -- | -- | |
| Cash From Financing | -$8.2B | $13.3B | -- | -- | -$14B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18.9B | $47.9B | -- | -- | -$22.6B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $26.6B | $32.1B | $10B | -$17B | -$8.8B | |
| Period Ending | 2021-03-28 | 2022-03-28 | 2023-03-28 | 2024-03-28 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CMWAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CMWAY
Sector
P/E ratio
24.68x
11.58x
PEG ratio
--
0.39x
P/B ratio
3.36x
1.08x
Price / LTM sales
8.93x
2.50x
Growth Metrics
CMWAY
Sector
Revenue growth
--
6.92%
Earnings growth
--
7.04%
Revenue (5-year growth)
1.65%
5.26%
Earnings forecast
--
$0.56
Profitability
CMWAY
Sector
Profitability FY 2024
--
$161.4M
Return on invested capital
3.73%
5.5%
Return on assets
0.76%
1%
Return on equity
13.22%
9.46%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
Aug
14
Estimated Next Earnings Date
May
14
Balance Sheet
CMWAY
Sector
Total cash
$51.5B
$475.2M
Short term investments
--
$261.5M
Total assets
$838.2B
$4.4B
Long term debt
$126.8B
$333.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
